Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 294

1.

Allergen immunotherapy now and in the future.

Nelson HS.

Allergy Asthma Proc. 2016 Jul;37(4):268-72. doi: 10.2500/aap.2016.37.3966.

PMID:
27401313
2.

Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma.

McGeachie MJ, Yates KP, Zhou X, Guo F, Sternberg AL, Van Natta ML, Wise RA, Szefler SJ, Sharma S, Kho AT, Cho MH, Croteau-Chonka DC, Castaldi PJ, Jain G, Sanyal A, Zhan Y, Lajoie BR, Dekker J, Stamatoyannopoulos J, Covar RA, Zeiger RS, Adkinson NF, Williams PV, Kelly HW, Grasemann H, Vonk JM, Koppelman GH, Postma DS, Raby BA, Houston I, Lu Q, Fuhlbrigge AL, Tantisira KG, Silverman EK, Tonascia J, Weiss ST, Strunk RC; CAMP Research Group.

N Engl J Med. 2016 May 12;374(19):1842-52. doi: 10.1056/NEJMoa1513737.

PMID:
27168434
3.

SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis.

Dahl R, Roberts G, de Blic J, Canonica GW, Kleine-Tebbe J, Nolte H, Lawton S, Nelson HS.

Allergy Asthma Proc. 2016 Mar-Apr;37(2):92-104. doi: 10.2500/aap.2016.37.3937. Epub 2016 Jan 21.

PMID:
26802643
4.

Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated.

Maloney J, Berman G, Gagnon R, Bernstein DI, Nelson HS, Kleine-Tebbe J, Kaur A, Li Q, Nolte H.

J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):301-9.e2. doi: 10.1016/j.jaip.2015.11.004. Epub 2016 Jan 2.

5.

Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe.

Nelson HS, Makatsori M, Calderon MA.

Immunol Allergy Clin North Am. 2016 Feb;36(1):13-24. doi: 10.1016/j.iac.2015.08.005. Review.

PMID:
26617224
6.

Short ragweeds is highly cross-reactive with other ragweeds.

Christensen LH, Ipsen H, Nolte H, Maloney J, Nelson HS, Weber R, Lund K.

Ann Allergy Asthma Immunol. 2015 Dec;115(6):490-495.e1. doi: 10.1016/j.anai.2015.09.016. Epub 2015 Oct 21.

PMID:
26507708
7.

Airway Obstruction Worsens in Young Adults with Asthma Who Become Obese.

Strunk RC, Colvin R, Bacharier LB, Fuhlbrigge A, Forno E, Arbelaez AM, Tantisira KG; Childhood Asthma Management Program Research Group.

J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):765-71.e2. doi: 10.1016/j.jaip.2015.05.009. Epub 2015 Jul 9.

PMID:
26164807
8.

Allergen immunotherapy: what's new, what's next?

Nelson HS.

Expert Rev Clin Immunol. 2015;11(9):959-61. doi: 10.1586/1744666X.2015.1062726. Epub 2015 Jul 1.

PMID:
26134252
9.

Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial.

Beasley RW, Donohue JF, Mehta R, Nelson HS, Clay M, Moton A, Kim HJ, Hederer BM.

BMJ Open. 2015 Feb 3;5(2):e006131. doi: 10.1136/bmjopen-2014-006131.

10.

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber.

Nolte H, Maloney J, Nelson HS, Bernstein DI, Lu S, Li Z, Kaur A, Zieglmayer P, Zieglmayer R, Lemell P, Horak F.

J Allergy Clin Immunol. 2015 Jun;135(6):1494-501.e6. doi: 10.1016/j.jaci.2014.12.1911. Epub 2015 Jan 27.

PMID:
25636947
11.

Recommendations for the pharmacologic management of allergic rhinitis.

Hoyte FC, Meltzer EO, Ostrom NK, Nelson HS, Bensch GW, Spangler DL, Storms WW, Weinstein SF, Katial RK.

Allergy Asthma Proc. 2014 May-Jun;35 Suppl 1:S20-7. doi: 10.2500/aap.2014.35.3761. Review.

PMID:
25582158
12.

Oral/sublingual Phleum pretense grass tablet (Grazax/Grastek) to treat allergic rhinitis in the USA.

Nelson HS.

Expert Rev Clin Immunol. 2014 Nov;10(11):1437-51. doi: 10.1586/1744666X.2014.963556. Review.

PMID:
25340426
13.

Update on house dust mite immunotherapy: are more studies needed?

Nelson HS.

Curr Opin Allergy Clin Immunol. 2014 Dec;14(6):542-8. doi: 10.1097/ACI.0000000000000104. Review.

PMID:
25115684
14.

New forms of allergy immunotherapy for rhinitis and asthma.

Nelson HS.

Allergy Asthma Proc. 2014 Jul-Aug;35(4):271-7. doi: 10.2500/aap.2014.35.3778. Review.

PMID:
24992546
15.

Allergen-specific immunotherapy.

Nelson HS, Norman PS.

Chem Immunol Allergy. 2014;100:333-8. doi: 10.1159/000360047. Epub 2014 May 22.

PMID:
24925414
16.

Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications.

Howrylak JA, Fuhlbrigge AL, Strunk RC, Zeiger RS, Weiss ST, Raby BA; Childhood Asthma Management Program Research Group.

J Allergy Clin Immunol. 2014 May;133(5):1289-300, 1300.e1-12.

17.

Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?

Nelson HS.

J Allergy Clin Immunol Pract. 2014 Mar-Apr;2(2):144-9; quiz 150-1. doi: 10.1016/j.jaip.2013.11.018. Review.

PMID:
24607040
18.

Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure.

Durham SR, Nelson HS, Nolte H, Bernstein DI, Creticos PS, Li Z, Andersen JS.

Allergy. 2014 May;69(5):617-23. doi: 10.1111/all.12373. Epub 2014 Mar 10.

19.

Pain perception and performance of three devices for single-site allergen skin testing.

Nelson HS, Lopez P, Curran-Everett D.

Allergy Asthma Proc. 2014 Jan-Feb;35(1):63-5. doi: 10.2500/aap.2014.35.3714.

PMID:
24433598
20.

Sublingual immunotherapy: the U.S. experience.

Nelson HS.

Curr Opin Allergy Clin Immunol. 2013 Dec;13(6):663-8. doi: 10.1097/ACI.0b013e328364580e. Review.

PMID:
24169432
Items per page

Supplemental Content

Loading ...
Write to the Help Desk